Folate-targeted drug-delivery systems prepared by nano-comminution

References

• Basa S, Muniyappan T, Karatgi P, Prabhu R, Pillai R. (2008). Production and in vitro characterization of solid dosage form incorporating drug nanoparticles. Drug Dev Ind Pharm, 34(11):1209–18.
   PubMed Web of Science ®Google Scholar
• Chen X, Matteucci ME, Lo CY, Johnston KP, Williams RO. (2009). Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders. Drug Dev Ind Pharm, 35(3):283–96.
   PubMed Web of Science ®Google Scholar
• Choi JY, Park CH, Lee J. (2008). Effect of polymer molecular weight on nanocomminution of poorly soluble drug. Drug Deliv, 15(5):347–53.
   PubMed Web of Science ®Google Scholar
• Crisp MT, Tucker CJ, Rogers TL, Williams RO, Johnston KP. (2007). Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals. J Control Release, 117(3):351–9.
   PubMed Web of Science ®Google Scholar
• Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, . (2006). Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release, 111(1–2):56–64.
   PubMed Web of Science ®Google Scholar
• Keck CM, Muller RH. (2006). Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm, 62(1):3–16.
   PubMed Web of Science ®Google Scholar
• Lee J, Cheng Y. (2006). Critical freezing rate in freeze drying nanocrystal dispersions. J Control Release, 111(1–2):185–92.
   PubMed Web of Science ®Google Scholar
• Lee MK, Kim MY, Kim S, Lee J. (2009). Cryoprotectants for freeze drying of drug nano-suspensions: Effect of freezing rate. J Pharm Sci, 98:4808–17.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18(2):113–20.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Van den Mooter G, Augustijns P. (2008). Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 364(1):64–75.
   PubMed Web of Science ®Google Scholar
• Kumar M, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. (2004). Chitosan chemistry and pharmaceutical perspectives. Chem Rev, 104(12):6017–84.
   PubMed Web of Science ®Google Scholar
• Rinaudo M. (2006). Chitin and chitosan: Properties and applications. Prog Polym Sci, 31:603–32.
   Web of Science ®Google Scholar
• Pillai CKS, Paul W, Sharma CP. (2009). Chitin and chitosan polymers: Chemistry, solubility and fiber formation. Prog Polym Sci, 31:603–32.
   Google Scholar
• Ojha SS, Stevens DR, Hoffman TJ, Stano K, Klossner R, Scott MC, . (2008). Fabrication and characterization of electrospun chitosan nanofibers formed via templating with polyethylene oxide. Biomacromolecules, 9(9):2523–9.
   PubMed Web of Science ®Google Scholar
• Chen H, Ouyang W, Lawuyi B, Prakash S. (2006). Genipin cross-linked alginate–chitosan microcapsules: Membrane characterization and optimization of cross-linking reaction. Biomacromolecules, 7(7):2091–8.
   PubMed Web of Science ®Google Scholar
• Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, . (2006). Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27(9):2060–5.
   PubMed Web of Science ®Google Scholar
• Hilgenbrink AR, Low PS. (2005). Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J Pharm Sci, 94(10):2135–46.
   PubMed Web of Science ®Google Scholar
• Lee J, Choi JY, Park CH. (2008). Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm, 355(1–2):328–36.
   PubMed Web of Science ®Google Scholar
• FDA Guidance for Industry. (2000 October). Bioavailability and bioequivalence studies for orally administered drug products—general considerations. Rockville, MD: FDA.
   Google Scholar
• FDA Guidance for Industry. (1997 August). Dissolution testing of immediate release solid oral dosage forms. Rockville, MD: FDA.
   Google Scholar
• FDA Guidance for Industry. (1997 September). Extended release solid oral dosage forms: Development, evaluation and application of in vitro/in vivo correlations. Rockville, MD: FDA.
   Google Scholar
• Siewert M, Dressman J, Brown CK, Shah VP, Aiache JM, Aoyagi N, . (2003). FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech, 4(1):43–52.
   Google Scholar
• Choi JY, Yoo JY, Kwak HS, Nam BU, Lee J. (2005). Role of polymeric stabilizers for drug nanocrystal dispersions. Curr Appl Phys, 5(5):472–4.
   Web of Science ®Google Scholar
• Kendall K. (1978). The impossibility of comminuting small particles by compression. Nature, 272:710–1.
   Web of Science ®Google Scholar
• Ploehn HJ, Russel WB. (1990). Interactions between colloidal particles and soluble polymers. Adv Chem Eng, 15:137–228.
   Google Scholar
• Lee J. (2003). Drug nano- and microparticles processed into solid dosage forms: Physical properties. J Pharm Sci, 92(10):2057–68.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. (2005). Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci, 24(5):441–9.
   PubMed Web of Science ®Google Scholar
• Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. (2002). Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm, 249(1–2):165–74.
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. (2000). A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int J Pharm, 201(1):51–8.
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. (2002). Controlled drug release properties of ionically cross-linked chitosan beads: The influence of anion structure. Int J Pharm, 233(1–2):217–25.
   PubMed Web of Science ®Google Scholar
• Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, . (2006). Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res, 23(6):1144–56.
   PubMed Web of Science ®Google Scholar
• Trickler WJ, Nagvekar AA, Dash AK. (2009). The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel. Pharm Res, 26(8):1963–73.
   PubMed Web of Science ®Google Scholar